Trial Details

TERMINATED
Basic Information
Clinical ID c1452
Identifier NCT03269695
Trial Title Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: PF-06687234|DRUG: Placebo
Participant Information
Sponsor Pfizer
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2017-12-20
Primary Completion Date 2021-01-07
Completion Date 2021-01-07